Global Trends in Research of Antimicrobial Peptides for the Treatment of Drug-Resistant Bacteria from 1995 to 2021: A Bibliometric Analysis

被引:1
作者
Liang, Yuelong [1 ]
Huang, Zhengze [1 ]
Shen, Xuqiu [1 ]
Zhang, Yiyin [1 ]
Chai, Yihan [1 ]
Jiang, Kexin [1 ]
Chen, Qi [2 ]
Zhao, Feng [3 ]
机构
[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Gen Surg, Hangzhou, Zhejiang, Peoples R China
[2] Hangzhou Fuyang Hosp Tradit Chinese Med, Dept Gen Surg, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China
来源
INFECTION AND DRUG RESISTANCE | 2023年 / 16卷
关键词
antimicrobial peptides; AMP; drug-resistant bacteria; bibliometric; POTENT; ANTIBIOTICS; AGENTS;
D O I
10.2147/IDR.S411222
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Antimicrobial peptides (AMPs) can act on the bacterial cell membrane to play an antibacterial role in types of drug resistant bacteria. Therefore, AMPs have attracted more and more attention in the treatment of drug-resistant bacteria.Methods: Bibliometric analysis was employed to sort out the development and trends in the research of AMPs in the treatment of drug-resistant bacteria and map the knowledge structure for scholars.Results: Since 2010, the publications and citations in this field have exploded, indicating a growing global interest in the field of AMPs for the treatment of drug-resistant bacteria. And as major countries in this field, China and the USA had conducted very indepth exchanges and cooperation, which had injected a steady stream of impetus into this field. Both old and new scholars have made efforts, and related fields have developed rapidly, especially in the synthesis and improvement of novel AMPs. In recent years, research directions in the field of AMPs for the treatment of drug-resistant bacteria gradually focused on the practical application, optimization of drug delivery mode, optimization of synthesis mode, screening of new AMPs and other fields, indicating that the relevant research results of AMPs for the treatment of drug-resistant bacteria had entered the actual clinical stage, with higher practical significance.Conclusion: The research history, global research status, future research hotspots, and trends of the research of AMPs in the treatment of drug-resistant bacteria were discussed in depth in this study, which can provide research references and inspiration for researchers inside and outside the related field.
引用
收藏
页码:4789 / 4806
页数:18
相关论文
共 49 条
  • [1] Amino Acid Conjugated Polymers: Antibacterial Agents Effective against Drug-Resistant Acinetobacter baumannii with No Detectable Resistance
    Barman, Swagatam
    Konai, Mohini Mohan
    Samaddar, Sandip
    Haldar, Jayanta
    [J]. ACS APPLIED MATERIALS & INTERFACES, 2019, 11 (37) : 33559 - 33572
  • [2] Pharmaceutical Machine Learning: Virtual High-Throughput Screens Identifying Promising and Economical Small Molecule Inhibitors of Complement Factor C1s
    Chen, Jonathan J.
    Schmucker, Lyndsey N.
    Visco, Donald P., Jr.
    [J]. BIOMOLECULES, 2018, 8 (02):
  • [3] Systemic antibacterial activity of novel synthetic cyclic peptides
    Dartois, V
    Sanchez-Quesada, J
    Cabezas, E
    Chi, E
    Dubbelde, C
    Dunn, C
    Granja, J
    Gritzen, C
    Weinberger, D
    Ghadiri, MR
    Parr, TR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) : 3302 - 3310
  • [4] Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response
    de la Fuente-Nunez, Cesar
    Reffuveille, Fany
    Haney, Evan F.
    Straus, Suzana K.
    Hancock, Robert E. W.
    [J]. PLOS PATHOGENS, 2014, 10 (05)
  • [5] Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood:: Implications for systemic applications
    Deslouches, B
    Islam, K
    Craigo, JK
    Paranjape, SM
    Montelaro, RC
    Mietzner, TA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) : 3208 - 3216
  • [6] Effects of Side Group Functionality and Molecular Weight on the Activity of Synthetic Antimicrobial Polypeptides
    Engler, Amanda C.
    Shukla, Anita
    Puranam, Sravanthi
    Buss, Hilda G.
    Jreige, Nina
    Hammond, Paula T.
    [J]. BIOMACROMOLECULES, 2011, 12 (05) : 1666 - 1674
  • [7] Antimicrobial Peptide K0-W6-Hya1 Induces Stable Structurally Modified Lipid Domains in Anionic Membranes
    Enoki, Thais A.
    Moreira-Silva, Isabela
    Lorenzon, Esteban N.
    Cilli, Eduardo M.
    Perez, Katia R.
    Riske, Karin A.
    Teresa Lamy, M.
    [J]. LANGMUIR, 2018, 34 (05) : 2014 - 2025
  • [8] Antibacterial agents based on the cyclic D,L-α-peptide architecture
    Fernandez-Lopez, S
    Kim, HS
    Choi, EC
    Delgado, M
    Granja, JR
    Khasanov, A
    Kraehenbuehl, K
    Long, G
    Weinberger, DA
    Wilcoxen, KM
    Ghadiri, MR
    [J]. NATURE, 2001, 412 (6845) : 452 - 455
  • [9] Antibacterial Gel Coatings Inspired by the Cryptic Function of a Mussel Byssal Peptide
    Fichman, Galit
    Andrews, Caroline
    Patel, Nimit L.
    Schneider, Joel P.
    [J]. ADVANCED MATERIALS, 2021, 33 (40)
  • [10] Bioengineered Nisin A Derivatives with Enhanced Activity against Both Gram Positive and Gram Negative Pathogens
    Field, Des
    Begley, Maire
    O'Connor, Paula M.
    Daly, Karen M.
    Hugenholtz, Floor
    Cotter, Paul D.
    Hill, Colin
    Ross, R. Paul
    [J]. PLOS ONE, 2012, 7 (10):